Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| BT-20 | MK 1775 | 0.316227766 | 0.7361 | 0.01461 |
| BT-20 | AZD5363 | 3.16227766 | 0.4374 | 0.12600 |
| BT-20 | MK 1775 | 0.1 | 1.0322 | 0.00099 |
| BT-20 | MK 1775 | 0.031622777 | 1.0694 | -0.00052 |
| BT-20 | MK 1775 | 0.031622777 | 1.1122 | 0.00541 |
| BT-20 | AZD5363 | 10.0 | 0.1717 | 0.07602 |
| BT-20 | MK 1775 | 0.1 | 1.0211 | 0.00281 |
| BT-20 | MK 1775 | 0.1 | 1.0953 | 0.00395 |
| BT-20 | MK 1775 | 3.16227766 | 0.3615 | 0.03778 |
| BT-20 | AZD6738 | 0.001 | 1.2570 | -0.00706 |
| BT-20 | BMS-265246 | 0.001 | 0.4851 | 0.00865 |
| BT-20 | BMS-265246 | 0.001 | 0.5460 | 0.01586 |
| BT-20 | BMS-265246 | 1.0 | -0.0350 | 0.05290 |
| BT-20 | MK 1775 | 0.001 | 0.9810 | 0.00009 |
| BT-20 | Senexin B | 10.0 | 0.0956 | 0.03023 |
| BT-20 | BMS-265246 | 0.001 | 0.6138 | 0.01261 |
| BT-20 | Ulixertinib | 3.16227766 | 0.8697 | 0.00204 |
| BT-20 | Senexin B | 3.16227766 | 0.6845 | 0.00493 |
| BT-20 | Senexin B | 3.16227766 | 0.5601 | 0.00550 |
| BT-20 | Senexin B | 10.0 | 0.1944 | 0.02576 |
| BT-20 | Senexin B | 1.0 | 0.5861 | 0.00458 |
| BT-20 | MK 1775 | 0.01 | 1.1372 | -0.00227 |
| BT-20 | Senexin B | 3.16227766 | 0.6111 | 0.02354 |
| BT-20 | Senexin B | 10.0 | 0.2429 | 0.02356 |
| BT-20 | Ribociclib | 0.01 | 0.5806 | 0.00124 |